Literature DB >> 12605592

P-selectin blockade fails to improve acute lung injury in sheep.

Abhijit Chandra1, Jiro Katahira, Frank C Schmalstieg, Kazunori Murakami, Perenlei Enkhbaatar, Robert A Cox, Hal K Hawkins, Lillian D Traber, David N Herndon, Daniel L Traber.   

Abstract

Accumulation of neutrophils in the lung contributes to the endothelial damage in the tissue associated with acute respiratory distress syndrome. This initial recruitment of neutrophils within the pulmonary microvasculature may involve P-selectin. Thus we hypothesized that an antibody against P-selectin would reduce pulmonary damage. Sheep were chronically instrumented and prepared. The first group received 40% body surface area third-degree burns with 48 breaths of cotton smoke and 1 mg/kg of anti-(P-selectin) antibody (termed 3D4) 1 h post injury (n = 5). The second group (non-treated) received the same injury but no antibody treatment (n = 6). The third group comprised of sham animals without any injury or antibody treatment (n = 6). Sheep were studied for 48 h during which they were uniformly resuscitated with Ringer's lactate solution by following the Parkland formula. All the animals were mechanically ventilated. In the non-treated injured group, the arterial partial pressure of O(2) ('PaO(2)')/inspired fraction of O(2) ('F(i)O(2)') ratio dropped to 168+/-30 at 48 h, whereas the lung lymph flow increased to an average of 46+/-9 ml/h (10-fold of baseline). These changes were not prevented by an anti-(P-selectin) antibody. The plasma and lymph nitrate/nitrite levels were lower in the antibody-treated group than in the non-treated group. The lymph conjugated dienes were significantly lower in the treated animals. However, lung myeloperoxidase activity and lung tissue conjugated dienes were significantly increased in the treated animals compared with the non-treated injured controls. In conclusion, although the anti-(P-selectin) antibody did not protect against lung injury during the initial 48 h of burn and smoke, it decreased some aspects of injury in the peripheral microcirculation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605592     DOI: 10.1042/CS20020244

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

Review 2.  Neutrophil Recruitment: From Model Systems to Tissue-Specific Patterns.

Authors:  Andreas Margraf; Klaus Ley; Alexander Zarbock
Journal:  Trends Immunol       Date:  2019-06-04       Impact factor: 16.687

3.  Arteriovenous CO2 removal improves survival compared to high frequency percussive and low tidal volume ventilation in a smoke/burn sheep acute respiratory distress syndrome model.

Authors:  Frank C Schmalstieg; Susan E Keeney; Helen E Rudloff; Kimberly H Palkowetz; Manuel Cevallos; Xiaoquin Zhou; Robert A Cox; Hal K Hawkins; Daniel L Traber; Joseph B Zwischenberger
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

4.  Respiratory burst function of ovine neutrophils.

Authors:  John-Paul Tung; John F Fraser; Peter Wood; Yoke Lin Fung
Journal:  BMC Immunol       Date:  2009-05-08       Impact factor: 3.615

5.  P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis.

Authors:  Muhammad Asaduzzaman; Milladur Rahman; Bengt Jeppsson; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

Review 6.  Endothelial Damage in Acute Respiratory Distress Syndrome.

Authors:  Alice G Vassiliou; Anastasia Kotanidou; Ioanna Dimopoulou; Stylianos E Orfanos
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

7.  Pharmaco-management of inhalation injuries for burn survivors.

Authors:  Anthony C Bartley; Dale W Edgar; Fiona M Wood
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 8.  Emerging therapies for smoke inhalation injury: a review.

Authors:  Alexandra Mercel; Nick D Tsihlis; Rob Maile; Melina R Kibbe
Journal:  J Transl Med       Date:  2020-03-30       Impact factor: 5.531

Review 9.  Targeting vascular inflammation through emerging methods and drug carriers.

Authors:  Jia Nong; Patrick M Glassman; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2022-03-07       Impact factor: 17.873

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.